This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Foukas, L. C.
Right arrow Articles by Shepherd, P. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Foukas, L. C.
Right arrow Articles by Shepherd, P. R.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, February 2004, p. 966-975, Vol. 24, No. 3
0270-7306/04/$08.00+0     DOI: 10.1128/MCB.24.3.966-975.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Regulation of Phosphoinositide 3-Kinase by Its Intrinsic Serine Kinase Activity In Vivo

Lazaros C. Foukas,1,{dagger} Caroline A. Beeton,1 Jorgen Jensen,2 Wayne A. Phillips,3 and Peter R. Shepherd1*

Department of Biochemistry and Molecular Biology, University College London, London WC1E 6BT, United Kingdom,1 Department of Physiology, National Institute of Occupational Health, 0033 Oslo, Norway,2 Peter MacCallum Cancer Institute, Melbourne, Victoria 8006, Australia3

Received 19 May 2003/ Returned for modification 26 June 2003/ Accepted 3 November 2003

One potentially important mechanism for regulating class Ia phosphoinositide 3-kinase (PI 3-kinase) activity is autophosphorylation of the p85{alpha} adapter subunit on Ser608 by the intrinsic protein kinase activity of the p110 catalytic subunit, as this downregulates the lipid kinase activity in vitro. Here we investigate whether this phosphorylation can occur in vivo. We find that p110{alpha} phosphorylates p85{alpha} Ser608 in vivo with significant stoichiometry. However, p110ß is far less efficient at phosphorylating p85{alpha} Ser608, identifying a potential difference in the mechanisms by which these two isoforms are regulated. The p85{alpha} Ser608 phosphorylation was increased by treatment with insulin, platelet-derived growth factor, and the phosphatase inhibitor okadaic acid. The functional effects of this phosphorylation are highlighted by mutation of Ser608, which results in reduced lipid kinase activity and reduced association of the p110{alpha} catalytic subunit with p85{alpha}. The importance of this phosphorylation was further highlighted by the finding that autophosphorylation on Ser608 was impaired, while lipid kinase activity was increased, in a p85{alpha} mutant recently discovered in human tumors. These results provide the first evidence that phosphorylation of Ser608 plays a role as a shutoff switch in growth factor signaling and contributes to the differences in functional properties of different PI 3-kinase isoforms in vivo.

* Corresponding author. Mailing address: Department of Biochemistry and Molecular Biology, University College London, Gower Street, London WC1E 6BT, United Kingdom. Phone: 44 20 7679 4482. Fax: 44 20 7679 7193. E-mail: p.shepherd{at}biochem.ucl.ac.uk.

{dagger} Present address: Ludwig Institute for Cancer Research, London W1W 7BS, United Kingdom.

Molecular and Cellular Biology, February 2004, p. 966-975, Vol. 24, No. 3
0022-538X/04/$08.00+0     DOI: 10.1128/MCB.24.3.966-975.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Houck, K. L., Fox, T. E., Sandirasegarane, L., Kester, M. (2008). Ether-linked diglycerides inhibit vascular smooth muscle cell growth via decreased MAPK and PI3K/Akt signaling. Am. J. Physiol. Heart Circ. Physiol. 295: H1657-H1668 [Abstract] [Full Text]  
  • Ciraolo, E., Iezzi, M., Marone, R., Marengo, S., Curcio, C., Costa, C., Azzolino, O., Gonella, C., Rubinetto, C., Wu, H., Dastru, W., Martin, E. L., Silengo, L., Altruda, F., Turco, E., Lanzetti, L., Musiani, P., Ruckle, T., Rommel, C., Backer, J. M., Forni, G., Wymann, M. P., Hirsch, E. (2008). Phosphoinositide 3-Kinase p110{beta} Activity: Key Role in Metabolism and Mammary Gland Cancer but Not Development. Sci Signal 1: ra3-ra3 [Abstract] [Full Text]  
  • Hale, B. G., Batty, I. H., Downes, C. P., Randall, R. E. (2008). Binding of Influenza A Virus NS1 Protein to the Inter-SH2 Domain of p85 Suggests a Novel Mechanism for Phosphoinositide 3-Kinase Activation. J. Biol. Chem. 283: 1372-1380 [Abstract] [Full Text]  
  • Kang, S., Denley, A., Vanhaesebroeck, B., Vogt, P. K. (2006). Oncogenic transformation induced by the p110beta, -{gamma}, and -{delta} isoforms of class I phosphoinositide 3-kinase. Proc. Natl. Acad. Sci. USA 103: 1289-1294 [Abstract] [Full Text]  
  • Bilancio, A., Okkenhaug, K., Camps, M., Emery, J. L., Ruckle, T., Rommel, C., Vanhaesebroeck, B. (2006). Key role of the p110{delta} isoform of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110{delta} function in B cells. Blood 107: 642-650 [Abstract] [Full Text]  
  • Shekar, S. C., Wu, H., Fu, Z., Yip, S.-C., Nagajyothi, , Cahill, S. M., Girvin, M. E., Backer, J. M. (2005). Mechanism of Constitutive Phosphoinositide 3-Kinase Activation by Oncogenic Mutants of the p85 Regulatory Subunit. J. Biol. Chem. 280: 27850-27855 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»